Changes in cytokine profile with immunotherapy in viral warts using purified protein derivative, mumps measles rubella vaccine, and mycobacterium w vaccine
Background: Immunotherapy for wart employs ability of immune system to recognize certain viral, bacterial, and fungal antigens in previously sensitized individual inducing Type IV delayed-type hypersensitivity reaction (up-regulated Th1 cytokines IL-1, TNF-α, IFN-γ; down-regulated Th2 cytokines IL-1...
Main Authors: | Amrita Sil, Sayantan Dasgupta, Somodyuti Chandra, Adrija Datta, Arini Banerjee, Nilay Kanti Das |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2021;volume=66;issue=1;spage=67;epage=73;aulast=Sil |
Similar Items
-
Intralesional purified protein derivative of tuberculin versus intralesional mycobacterium W vaccine in treatment of recalcitrant extragenital warts: A randomized, single-blinded, comparative study
by: Alpana Mohta, et al.
Published: (2022-01-01) -
A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine
by: Achdiat PA, et al.
Published: (2023-11-01) -
A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
by: Pragya Gupta, et al.
Published: (2020-01-01) -
Intralesional measles, mumps and rubella vaccine versus formic acid puncture in the treatment of common warts: A prospective randomised study
by: Myfanwy J D'Souza, et al.
Published: (2023-01-01) -
An intention-to-treat-analysis of the efficacy of immunotherapy using Mycobacterium w vaccine and Purified Protein Derivative of Tuberculin for warts with assessment of improvement in quality of life
by: Alpana Mohta, et al.
Published: (2022-05-01)